Spots Global Cancer Trial Database for Quantitative Immunochemical Fecal Occult Blood Test in Symptomatic Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Quantitative Immunochemical Fecal Occult Blood Test in Symptomatic Patients

Official Title: Quantitative Immunochemical Fecal Occult Blood Test in Symptomatic Patients

Study ID: NCT02491593

Conditions

Colorectal Neoplasms

Interventions

fecal occult blood test

Study Description

Brief Summary: The aim of this study is to compare the outcome of three (3) quantitative immunochemical faecal occult blood test in symptomatic patients.

Detailed Description: Consecutive patients referred from primary care for colonoscopy due to symptoms are eligible. Patients will receive written information of the study together with the time for colonoscopy. A specific research nurse will call them and for those accepting participation, history and current medication will be collected. Kits will be sent to patients and they will provide three faecal samples before examination. These will be analysed at one certified laboratory. Hemoglobin concentration will be notified in the range of 50 - \< 1000 ng/mL, or as a negative outcome. Macroscopic findings at the colonoscopy will be collected, as well as the outcome of the pathological report.